«Production of Lentivirus particles pseudotyped with SARS-CoV-2 spike protein for neutralisation or drug antiviral activity assays». One Health & Risk Management (desember 13, 2023): 77. åpnet juli 22, 2026. https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/657.